Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn C Fitzgerald

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
The Lancet. Neurology|March 22, 2025
SARS-CoV-2 infection in people with multiple sclerosisKathryn C Fitzgerald
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
Obesity's role in MS: An intervention target with possible interactionsKathryn C Fitzgerald, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - CommentaryKathryn C Fitzgerald, Ellen M Mowry
Current Allergy and Asthma Reports|July 4, 2023
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic ApproachesEleni S Vasileiou, Kathryn C Fitzgerald
Annals of Neurology|September 30, 2017
Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis"Kathryn C Fitzgerald, Kassandra L Munger, Alberto Ascherio
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2023
Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activityNicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry
JAMA Neurology|February 5, 2019
Reporting of R2 Statistics for Mixed-Effects Regression ModelsElias S Sotirchos, Kathryn C Fitzgerald, Ciprian M Crainiceanu
Scientific Reports|February 11, 2023
Different risk factors distinguish myalgic encephalomyelitis/chronic fatigue syndrome from severe fatigueNatalia Palacios, Samantha Molsberry, Kathryn C Fitzgerald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2024
Association between demographics, socioeconomics, and disease-related factors and the perception of stigma in people with MSMahsa Ghajarzadeh, Kathryn C Fitzgerald, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2021
Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohortKathryn C Fitzgerald, Anne Damian, Devon Conway, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
The Lancet. Neurology|March 22, 2025
SARS-CoV-2 infection in people with multiple sclerosisKathryn C Fitzgerald
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
Obesity's role in MS: An intervention target with possible interactionsKathryn C Fitzgerald, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - CommentaryKathryn C Fitzgerald, Ellen M Mowry
Current Allergy and Asthma Reports|July 4, 2023
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic ApproachesEleni S Vasileiou, Kathryn C Fitzgerald
Annals of Neurology|September 30, 2017
Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis"Kathryn C Fitzgerald, Kassandra L Munger, Alberto Ascherio
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2023
Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activityNicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry
JAMA Neurology|February 5, 2019
Reporting of R2 Statistics for Mixed-Effects Regression ModelsElias S Sotirchos, Kathryn C Fitzgerald, Ciprian M Crainiceanu
Scientific Reports|February 11, 2023
Different risk factors distinguish myalgic encephalomyelitis/chronic fatigue syndrome from severe fatigueNatalia Palacios, Samantha Molsberry, Kathryn C Fitzgerald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2024
Association between demographics, socioeconomics, and disease-related factors and the perception of stigma in people with MSMahsa Ghajarzadeh, Kathryn C Fitzgerald, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2021
Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohortKathryn C Fitzgerald, Anne Damian, Devon Conway, et al.
Pageof 18